Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Clinical trial NCT05150652 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05150652
Sponsor: Irada Ibrahim-zada
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-negative Breast Cancer Node-negative Breast Cancer Breast Carcinoma

Start date: 2022-02-18
Primary completion: 2025-12-09
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.